Simulations Plus, Inc.SLP決算レポート
Nasdaq · 情報技術 · コンピュータ統合システム設計サービス
Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity (ADMET) modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services.
What changed in Simulations Plus, Inc.'s 10-K — 2024 vs 2025
No meaningful paragraph-level changes detected in the compared sections. Either the two filings are nearly identical or the sections did not parse.